Changzhou Qianhong Biopharmaceutical Co., Ltd. (hereinafter referred to as "the Company") received a notice from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") on January 23, 2026, regarding the acceptance of the application documents for the issuance of convertible bonds to unspecified objects (SZSE Review [2026] No. 19). The SZSE verified the application documents submitted by the Company and deemed them complete, deciding to accept the application. On February 12, 2026, the Company received an inquiry letter from the SZSE regarding its application to issue convertible bonds to unspecified objects (Inquiry Letter [2026] No. 120011). The SZSE's listing review
002550SZSE
Announcement on the Response to the Inquiry Letter Regarding the Issuance of Convertible Bonds to Unspecified Objects and Updates to Application Documents
✨ AI Summary
This announcement informs that Changzhou Qianhong Biopharmaceutical Co., Ltd. has received and responded to an inquiry from the Shenzhen Stock Exchange regarding its application to issue convertible bonds. The company has updated its application documents, including the prospectus, following the inquiry. The issuance is still subject to approval by the Shenzhen Stock Exchange and the China Securities Regulatory Commission.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.